Yiran Gan 4/8/25 Yiran Gan 4/8/25 Changes in plasma biomarkers differentiate clinical stages of Alzheimer's disease using immunomagnetic reduction assays Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Theoretical Explorations of Reductions in The Alternative-current Magnetic Susceptibility of Reagent in Immunomagnetic Reduction Assay Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Biomarker Assessment in Parkinson’s Disease Dementia and Dementia with Lewy Bodies by the Immunomagnetic Reduction Assay and Clinical Measures Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Longitudinal assessment of plasma biomarkers for early detection of cognitive changes in subjective cognitive decline Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Differential neuropsychiatric associations of plasma biomarkers in older adults with major depression and subjective cognitive decline Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 White matter alterations and their associations with biomarkers and behavior in subjective cognitive decline individuals: a fixel-based analysis Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 The Ratio of Plasma Amyloid-β 1-42 over Serum Albumin Can Be a Novel Biomarker Signature for Diagnosing End-Stage Renal Disease-Associated Cognitive Impairment Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Thickness, Annealing, and Surface Roughness Effect on Magnetic and Significant Properties of Co40Fe40B10Dy10 Thin Films Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Studying the Effects of Annealing and Surface Roughness on Both the Magnetic Property and Surface Energy of Co60Fe20Sm20 Thin Films on Si(100) Substrate Read More Newer Posts Older Posts
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Changes in plasma biomarkers differentiate clinical stages of Alzheimer's disease using immunomagnetic reduction assays Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Theoretical Explorations of Reductions in The Alternative-current Magnetic Susceptibility of Reagent in Immunomagnetic Reduction Assay Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Biomarker Assessment in Parkinson’s Disease Dementia and Dementia with Lewy Bodies by the Immunomagnetic Reduction Assay and Clinical Measures Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Longitudinal assessment of plasma biomarkers for early detection of cognitive changes in subjective cognitive decline Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Differential neuropsychiatric associations of plasma biomarkers in older adults with major depression and subjective cognitive decline Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 White matter alterations and their associations with biomarkers and behavior in subjective cognitive decline individuals: a fixel-based analysis Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 The Ratio of Plasma Amyloid-β 1-42 over Serum Albumin Can Be a Novel Biomarker Signature for Diagnosing End-Stage Renal Disease-Associated Cognitive Impairment Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Thickness, Annealing, and Surface Roughness Effect on Magnetic and Significant Properties of Co40Fe40B10Dy10 Thin Films Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Studying the Effects of Annealing and Surface Roughness on Both the Magnetic Property and Surface Energy of Co60Fe20Sm20 Thin Films on Si(100) Substrate Read More
